4
Changes in Ownership
Fulgent Genetics, Inc. Filed Acc 0001209191-20-045395
Chief Operating Officer sold 1,976 shares at $27.86 ($55,055)
- Chief Operating Officer acquired 200,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Xie Jian · Chief Operating Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-08-03 | Grant or award : show line 1 in the form | +200,000 | 603,712 | D | ||
| 2020-08-03 | Sale : show line 2 in the form | −1,976 | $27.86 | $55,055 | 601,736 | D |
| Open-market sales · 1,976 sh · avg $27.86 · $55,055 | ||||||
Loading xslF345X03/doc4.xml…